Company profile: Network Partners
1.1 - Company Overview
Company description
- Provider of professional services and life sciences professionals to medical device, pharmaceutical, and biopharmaceutical industries, with core competencies in Regulatory Affairs, Medical Writing, Packaging Engineering, Labeling, Quality, and Project Management to help clients complete the work necessary to deliver products to patients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Network Partners
Acurian
HQ: United States
Website
- Description: Provider of patient and doctor recruitment, enrollment and retention solutions for clinical trials, including recruitment feasibility, site identification and selection, data-driven patient recruitment, an integrated network for AES research sites, geo-targeted vaccine volunteer enrollment via a global site network, specialized strategies for challenging indications (Alzheimer's, NASH), and cancer solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acurian company profile →
Nivagen Pharmaceuticals
HQ: United States
Website
- Description: Provider of generic prescription drugs and over-the-counter healthcare products for the North American market, engaged in development, acquisition, and sales. Leverages global partnerships with FDA-approved manufacturers to deliver affordable, high-quality products, including Carbamazepine, Celecoxib, Chlorthalidone, and Diclofenac Sodium/Misoprostol.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nivagen Pharmaceuticals company profile →
Nexelis
HQ: United States
Website
- Description: Provider of assay development and advanced laboratory testing; a portfolio company of Ampersand Capital Partners.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nexelis company profile →
Patheon
HQ: United States
Website
- Description: Provider of commercial manufacturing and pharmaceutical development services to pharmaceutical and biotechnology industries worldwide, spanning solid, semi-solid, liquid, and sterile dosage forms. Offers contract development and manufacturing from preclinical to commercialization, clinical trial strategy and operations, commercial services, advanced therapies (viral vectors, cell therapy, mRNA), biologics, and small molecule development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Patheon company profile →
Nordic Bioscience
HQ: Denmark
Website
- Description: Provider of ECM-focused biomarker technologies and services for precision drug development, including Protein Fingerprint technology to quantify extracellular matrix fragments in blood, laboratory biomarker analysis for clinical trials, the PRO-C3 biomarker for type III collagen formation, and the GRIPonMASH platform for early MASH detection and management with AI-based decision support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nordic Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Network Partners
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Network Partners
2.2 - Growth funds investing in similar companies to Network Partners
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Network Partners
4.2 - Public trading comparable groups for Network Partners
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →